ABEO: Q2 2026 net revenue rose 31% to $11.4M as ZEVASKYN expanded to seven QTCs and gained NTAP statusQuartr·1 day ago, 09:28 AMABEO-5.36%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·1 day ago, 07:05 AMABEO-5.36%NRC+1.24%
Abeona Therapeutics shares are trading lower after the company reported worse-than-expected Q2 financial results.benzinga_article·1 day ago, 06:59 AMABEO-5.36%
CMS grants NTAP reimbursement status for Abeona gene therapy ZEVASKYN under FY2027 IPPS rulePUBT·Aug 4 at 06:32 AMABEO-5.36%
Abeona Therapeutics grants 10,800 restricted shares to new hires under Nasdaq inducement rulePUBT·Aug 3 at 06:30 AMABEO-5.36%
Notus BV raises stake in Abeo to 10.51% of capital, 6.56% voting rightsPUBT·Jul 6 at 06:12 AMABEO-5.36%
Abeo reports 8,330,917 issued shares, 13,343,464 total voting rights as of June 30, 2026PUBT·Jul 3 at 01:15 PMABEO-5.36%
Abeona Therapeutics Insider Move Sparks Fresh Interest From InvestorsTip Ranks·Jul 2 at 09:04 PMABEO-5.36%
